CD8A and esophageal squamous cell carcinoma: Mouse studies in esophageal squamous cell carcinoma (ESCC) reveal that preventative PD-1 blockade at early ESCC stages potently increases CD8+CD103+ TRM cell infiltration, delays lesion progression, and, upon re-exposure to carcinogen, maintains TRM cell colonies that mediate prolonged survival [54].